Managed Care Pharmacy Issues

View an executive summary of the key findings from the AMCP 2024 Access, Affordability and Outcomes: The Value of Managed Care Pharmacy report.

AMCP supports the recognition of pharmacists as providers. When pharmacists are recognized as provider members of the health care team, patient outcomes improve, and patients report higher rates of satisfaction while overall health care costs are reduced. Recognized provider status would allow pharmacists to be reimbursed for providing health care services to patients. In a survey conducted in 2023 commissioned by Wolters Kluwer Health, 58% of Americans agreed that they are more likely to seek non-emergency medical care from a pharmacist.

View the 2024 AAO Report to learn how managed care pharmacy professionals facilitate appropriate access to prescription treatments and promote affordability to help improve outcomes for patients across America’s health care system.

In its second year, AMCP's annual Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy 2024 report looks at the fundamental concepts of managed care pharmacy and provides insight and clarity into how today's changing health care climate can be navigated to improve patient care and outcomes.

Welcome to the first Professional Affairs blog! We plan on sharing a periodic post to recap some of the major news, journal articles, reports, and other publications from around the web that have come out since our last post. As this is our first blog, we’ll try to adequately cover the whirlwind that was July and early August 2024.

Download the AMCP Engagement Framework at AMCP.org for Payers and Patient Organizations to find various resources, tools, examples, and instructions to guide payers and patient organizations in opening lines of communication to assist with incorporating the patient’s voice in decision-making processes.

PDTs offer significant promise in treating certain conditions and improving access to care, but participants agreed that a new modality requires new approaches to coverage. This brief is intended to help prepare the American health care system to begin covering PDTs.